MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Noise assessment acoustic measures of sustained vowel in patients with Parkinson’s disease

    I. Khasanov, D. Khasanova (Kazan, Russian Federation)

    Objective: To investigate and quantify the presence of noise in the vocal signals of Parkinson's disease (PD) patients and healthy volunteers (HV) using acoustic measures,…
  • 2025 International Congress

    Advancing the Quality of Life of Parkinson’s Disease (PD) Patients in Ethiopia: The Impact of Self-Management and Coping Skills Training Programs on Patients in a Resource Constrained Settings

    T. Yinesu, Z. Bayu (Addis Ababa, Ethiopia)

    Objective: Evaluating the effectiveness of training in self-management and coping skills for patients with PD Background: The Parkinson’s Patients Support Organization Ethiopia (PPSO-E) implemented a…
  • 2025 International Congress

    Impact of Gastrointestinal Dysfunction Symptoms on Psychomotor Recovery Following 8-Week Aerobic Interval Training in Parkinson’s Disease – Preliminary Results

    K. Lorek, K. Markowska, A. Bereza, E. Koziorowska, S. Budrewicz, P. Nowakowski, S. Chomiak (Wroclaw, Poland)

    Objective: To investigate the impact of gastrointestinal dysfunction symptoms (GIDS) on psychomotor recovery following 8-week aerobic interval training (AIT) in Parkinson's disease (PD). Background: GIDS…
  • 2025 International Congress

    Impact of ND0612 on Levodopa-Induced Dyskinesia in Parkinson’s Disease: Post hoc Analyses From a Randomized, Active-Controlled Study

    A. Ellenbogen, R. Pahwa, J. Hernández-Vara, N. Lopes, J. Pereira, A. Espay (Farmington Hills, USA)

    Objective: To evaluate dyskinesia-related outcomes between optimized subcutaneously administered levodopa/carbidopa (ND0612) + immediate-release levodopa/carbidopa (IR-LD/CD) vs optimized oral IR-LD/CD in patients with Parkinson’s disease (PD).…
  • 2025 International Congress

    Development and Validation of Personal Technology to Treat Hypophonia in Patients with Parkinson’s Disease

    A. Klein, A. Gillespie, D. Anderson, M. Caveney, N. Sundholm (Atlanta, USA)

    Objective: The purpose of this study was to develop and validate wearable technology to improve vocal intensity in patients with Parkinson’s Disease. Background: Parkinson’s disease…
  • 2025 International Congress

    Increased “Off” Time Is Associated With Poorer Clinical and Humanistic Outcomes in Patients With Advancing Parkinson’s Disease: Results From the PROSPECT Observational Study

    P. Sanchez Alonso, D. Houghton, F. Ory-Magne, T. Oeda, D. Safarpour, L. Bergmann, P. Kukreja, K. Onuk, S. Wang, C. Yan, D. Standaert (Majadahonda, Spain)

    Objective: To evaluate the association of increased “Off” time with clinical and humanistic outcomes in people with advanced Parkinson’s disease (PwP) inadequately managed by oral…
  • 2025 International Congress

    Barriers and Facilitators of Adherence to Mediterranean-Ketogenic and MCT-Supplemented Mediterranean Diets in Parkinson’s Disease: A Qualitative Secondary Analysis from a Random-Order Crossover Trial

    K. Tosefsky, Y. Wang, J. Lam, A. Kuan, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To assess the barriers and facilitators of dietary adherence among people with Parkinson’s disease (PD) following an 8-week Mediterranean-ketogenic and 8-week MCT-supplemented Mediterranean diet.…
  • 2025 International Congress

    Effect of Reaction Oriented Training on Postural Stability and Reaction Time in Parkinsons’s Disease

    M. Salamci, A. Guclu-Gunduz, C. Ozkul, R. Yılmaz, M. Akbostancı (Ankara, Turkey)

    Objective: This study aimed to examine the effect of reaction-oriented training (ROT), a novel rehabilitation approach developed for people with Parkinson's disease (pwPD), on postural…
  • 2025 International Congress

    Differential Motor Cortex Compensation in Parkinson’s Disease based on Putamen Neurodegeneration Laterality: Insights from EEG and [¹⁸F]FDOPA PET/CT

    K. Lorek, J. Mączewska, L. Królicki, K. Markowska, M. Koszewicz, S. Budrewicz, M. Chalimoniuk, J. Marusiak (Wroclaw, Poland)

    Objective: To investigate differences in motor cortex compensation across Parkinson’s disease (PD) patients with different putamen neurodegeneration laterality. Background: Abnormalities in the putamen–motor cortex (M1)…
  • 2025 International Congress

    Modeling Levodopa Resistance in Parkinson’s Disease: A Novel Approach Targeting Locus Coeruleus Degeneration

    A. Goel, R. Goel (Bathinda, India)

    Objective: To develop a Parkinson’s disease (PD) model replicating levodopa (LD) resistance by incorporating degeneration of both the substantia nigra (SN) and locus coeruleus (LC),…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley